Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors

Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension and pulmonary...

Related Keywords

United States ,Spain ,American ,Spanish ,Skye Drynan ,Stevend Nathan ,Faheem Hasnain ,Inova Advanced Lung Disease Program ,House Of Skye Ltd ,American Thoracic Society ,University Of Witwatersrand Medical School ,Nasdaq ,International Society For Heart ,American College Of Chest Physicians ,Senior Biopharma Analyst At Capital Group ,Gossamer Bio Inc ,Wellesley College ,Senior Biopharma Analyst For Capital Group ,Vernon Associates ,Putnam Investments ,Capital Group ,Bloomberg ,Whitehead Institute For Biomedical Research ,University Of Virginia ,Lung Transplant Program ,Gossamer Bio ,Medical Director ,Advanced Lung Disease Program ,Creative Director ,Senior Biopharma Analyst ,Medical Education ,Idiopathic Pulmonary Fibrosis ,Clinical Management ,Idiopathic Pulmonary ,American College ,Chest Physicians ,International Society ,Witwatersrand Medical ,Nuda Foods ,Portfolio Manager ,Global Head ,Suisse Asset ,Lord Abbett ,New Vernon Associates ,Latin American Studies ,Research Assistant ,Whitehead Institute ,Biomedical Research ,Markets ,